TENX News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

TE

Mkt Cap

$50.9M

Volume

1.45M

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026Tenax Therapeutics presented additional Phase 3 LEVEL trial results for TNX-103 (oral levosimendan) in patients with pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF). While the primary endpoint of 6-minute walk distance improvement did not achieve statistical significance in the overall population, prespecified subgroup analyses showed favorable results in patients with baseline 6MWD below 333 meters, including a 26.3-meter improvement in walk distance and a 47% reduction in NT-proBNP. The company plans to enrich the LEVEL-2 trial population based on these findings.GlobeNewswire Inc. · Aug 29, 2026

Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial OfficerTenax Therapeutics announced the appointment of Timothy Healey as Chief Commercial Officer effective immediately. Healey is a seasoned pharmaceutical executive with extensive commercial leadership experience from companies including Eversana, Lantheus, AbbVie, and AMAG Pharmaceuticals. He will oversee global commercial strategy and prepare TNX-103 for market launch as the company advances its Phase 3 clinical trials.GlobeNewswire Inc. · May 4, 2026

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025Tenax Therapeutics will participate in the Cantor Global Healthcare Conference 2025, presenting a fireside chat about their ongoing Phase 3 LEVEL Study for pulmonary hypertension treatment, with patient enrollment expected in first half of 2026.GlobeNewswire Inc. · Aug 28, 2025

Plastic Fencing Market to be Driven by Growing Residential and Commercial Construction Activities, Exclusive Research by The Insight PartnersThe global plastic fencing market is expected to grow significantly due to rising demand from the residential and commercial construction industries, as well as the increasing adoption of recycled plastics in fencing products.GlobeNewswire Inc. · Mar 19, 2025

Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech ConferenceTenax Therapeutics, a Phase 3 pharmaceutical company, announced its participation in the Guggenheim SMID Cap Biotech Conference, where its President and CEO will present in a fireside chat.GlobeNewswire Inc. · Jan 31, 2025

Trump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health CareThe White House has ordered a temporary freeze on all federal grants and loans, putting $3 trillion in funding under scrutiny and threatening industries like clean energy, defense, and healthcare.Benzinga · Jan 28, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsightThe article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.GlobeNewswire Inc. · Jan 14, 2025

Behavioral Rehabilitation Market to Witness 6.9% CAGR by 2031 | SkyQuest TechnologyThe behavioral rehabilitation market is expected to grow rapidly, driven by increasing mental health awareness and the rising global addiction crisis. The substance abuse disorder segment dominates the market, with a focus on personalized treatments and innovations in telemedicine. North America leads the market due to high awareness of dementia and a strong healthcare system.GlobeNewswire Inc. · Nov 22, 2024

Ensign Adds 8 Facilities in Kansas & Colorado to Expand FootprintThe Ensign Group has acquired the operations of a nursing facility in Kansas and seven nursing facilities in Colorado, expanding its footprint in these states. The acquisitions are expected to increase the company's revenues and profits.Benzinga · Sep 5, 2024

Europe Pavement Reinforcement Materials (Carbon Fiber, Glass Fiber, Steel Rebar) Industry Analysis Report 2024-2030The Europe pavement reinforcement materials market is expected to grow at a CAGR of 8.3% from 2024 to 2030, driven by increasing urbanization, smart city initiatives, and the shift towards alternative transportation modes. Key materials include carbon fiber, glass fiber, and steel rebar.GlobeNewswire Inc. · Aug 20, 2024

TE

TENXTenax Therapeutics, Inc.

TENX

Pay with—

Available Balance0.00

Your PositionYou don't own any TENX yet.

Related Tickers

Earnings